Translating Research into Practice

Dr. Robert Vonderheide, Abramson Cancer Center Director

Robert Vonderheide, MD, DPhil

Director of the Abramson Cancer Center of the University of Pennsylvania

World Leaders in Cancer Research

Changing the Future of Cancer Research and Care

When former Director Chi V. Dang, MD, PhD, joined Penn Medicine's Abramson Cancer Center, one of his key priorities was to create flagship medical programs that would bring together experts from diverse fields to address major challenges in cancer care.

He invited faculty from the Penn community to form teams and develop multidisciplinary, disease-specific Translational Centers of Excellence (TCEs) aimed at finding solutions to the most pressing issues confronting cancer patients.

In his position as the new Abramson Cancer Center Director, Robert H. Vonderheide, MD, DPhil, will usher this program through the next phase as the more TCEs are selected, and the existing TCEs mature into research centers.

Following an extensive application and scientific review process, the following TCEs were selected for funding:

Fueling Innovation and Propelling Discovery

Translational Centers of Excellence are narrowing the gap between the clinic and the laboratory, accelerating the pace of discoveries that will help today's patients become — and remain — cancer-free. They bring together the most brilliant minds from across the Penn system, from basic scientists to engineers, inspiring one another to work together to solve cancer's most complex challenges — and create possibilities that have never been dreamed.